Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate

Catalog No. :
ACCWUD583
CAS No. :
148550-51-0
Molecular Formula :
C8H10N2O4S
Molecular Weight :
230.24

IUPAC Name:ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate

Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$113.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(methylsulfonyl)pyrimidine-5-carboxylate
IUPAC Nameethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate
MDL No.MFCD07366751
Molecular FormulaC8H10N2O4S
Molecular Weight230.24
SMILESO=C(C1=CN=C(S(=O)(C)=O)N=C1)OCC
InChI KeySHVJIPVRIOSGCA-UHFFFAOYSA-N
Synonym2-(Methylsulfonyl)-5-pyrimidinecarboxylic acid ethyl ester;ETHYL 2-(METHYLSULFONYL)PYRIMIDINE-5-CARBOXYLATE;ETHYL 2-(METHYLSULPHONYL)PYRIMIDINE-5-CARBOXYLATE;Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate 95%;5-Pyrimidinecarboxylic acid, 2-(methylsulfonyl)-, ethyl ester;ETHYL 2-(METHYLSULFONYL)PYRIMIDINE-5-CARBOXYLATE ISO 9001:2015 REACH;Ethyl 2-(Methylsulfonyl)-5-pyrimidinecarboxylate
CAS No.148550-51-0
PubChem CID254889

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACCWUD583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTUCM853 route compound structure diagram
    ACTUCM85373781-88-1 In Stock
  2. Then
  3. ACCWUD583 route product structure diagram
    ACCWUD583148550-51-0 In Stock
Inquiry

2. ACCWUD583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTUCM853 route compound structure diagram
    ACTUCM85373781-88-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCWUD583 route product structure diagram
    ACCWUD583148550-51-0 In Stock
Inquiry

Comments (0)